Back

CMR in immune checkpoint inhibitor-associated myocarditis: do standard CMR diagnostic criteria apply?

11 December 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: CMR in contemporary cardio-oncology Myocardial Disease EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Lars Michel

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

4 More presentations in this session

Presentation thumbnail
Role of CMR in contemporary cardio-oncology: where does it fit in?
Professor A. Barac (Fairfax, US)
Slides Video
Presentation thumbnail
CMR as biomarker of cardiotoxicity: evidence-based for CMR in cardio-oncology
Professor C. Manisty (London, GB)
Slides Video
Presentation thumbnail
Optimising the use of CMR in my cardio-oncology practice
Professor A. Ghosh (London, GB)
Slides Video
Presentation thumbnail
CMR in contemporary cardio-oncology - discussion
Video

Access the full session

Session thumbnail
CMR in contemporary cardio-oncology
Video

The Event

Event poster

EACVI 2025

11 December - 13 December 2025
You may be interested in
thumbnail
Congress Presentation
Routine application of cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy
thumbnail
Congress Presentation
Immune checkpoint inhibitor-associated myocarditis: a rare presentation with electrical storm in a young patient with Hodgkin lymphoma
thumbnail
Congress Presentation
When an anticancer drug silently attacks the heart - severe but due to diabetic neuropathy oligosymptomatic immune checkpoint inhibitor-associated perimyocarditis with LV outflow tract obstruction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources